Pfizer Inc. said Monday it'll pay up to $680 million to buy private firm NextWave Pharmaceuticals for up to $680 million
The deal includes a payment of $255 million to NextWave shareholders, plus up to $425 million more based on sales milestones
NextWave is focused on the development and commercialization of products for the treatment of attention deficit/hyperactivity and related central nervous system disorders
No hay comentarios:
Publicar un comentario